Equity · Healthcare
CERS
NASDAQCerus Corporation
The line runs $3.12 on 21 July through $2.17 on 16 October, on a scale from $2.0 to $3.5. Days the market did not trade hold the previous close, flat.
as of Oct 16, 2026
CERS insider trades
CERS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 24 November 2025.
CERS reported financials
SEC EDGARCERS reported revenue of $233.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$15.6M.
CERS earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
CERS institutional holders
SEC EDGAR9 of the 45 institutional funds we track reported a CERS position for the quarter ended 30 Jun 2026 — a combined $107.8M; the latest of those filings landed 02 Sep 2026.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SEC EDGARValuation computed from SEC EDGAR filings